AirSculpt Technologies, Inc.

NASDAQ:AIRS

Medical - Care Facilities

Healthcare
$0.72 +4.45%

+$0.21 today

Market cap
$53.08M
Beta
2.34
P/E (TTM)
-31.1
EPS (TTM)
-$0.16
52W Low $1.51High $12.00

Volume 0.49M

Average 1.46M

AIRS Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

AirSculpt Technologies, Inc.NASDAQ: AIRS

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation declines year over year

Q1 FY2026 stock-based compensation of $559K fell 54.9% year over year, behind the -43.9% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 84.3% from the prior quarter. Over 3 fiscal years it compounded at -57.1% a year.

Context

  • Stock-based compensation amounted to 1.5% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Stock-based compensation increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -54.9% toward the trailing-twelve-month pace of -43.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$559K-84.3% QoQ
Last fiscal yearDec 2025
$2.33M-38.0% YoY
LTMMar 2026
$6.61M-43.9% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-54.9%——
1 year-38.0%——
3-year CAGR-57.1%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
2.33M USD
Year-over-year change
-38.0%
4-year CAGR
-24.5%

Stock-Based Compensation vs competitors

How AIRS compares with its peers on the latest reported figures

  • AIRS's LTM Mar 2026 stock-based compensation of $6.61M is the 8th largest of the 11 companies compared; the peer median is $11.07M.
  • Its year-over-year change of -43.9% is the 7th highest of 10, against a peer median of -2.4%.
  • Stock-based compensation amounts to 4.4% of revenue for AIRS, versus a peer median of 5.6%.
AIRS Competitors Peer median
Stock-Based Compensation for AIRS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OFIXOrthofix Medical Inc.LTM Mar 2026$42.3M +40.4%+15.9%5.1%
AMNAMN Healthcare Services, Inc.LTM Mar 2026$31.19M +25.0%+0.7%0.9%
SIBNSI-BONE, Inc.LTM Mar 2026$24.89M -2.4%+3.4%12.1%
MLTXMoonLake ImmunotherapeuticsLTM Mar 2026$23.96M +203.5%+10.1%—
CMPSCOMPASS Pathways plcLTM Mar 2026$12.55M -31.5%+1.2%—
PACBPacific Biosciences of California, Inc.LTM Mar 2026$9.59M -84.2%-19.1%6.0%
AQSTAquestive Therapeutics, Inc.LTM Mar 2026$8.36M +17.6%+20.3%16.6%
AIRSAirSculpt Technologies, Inc.LTM Mar 2026$6.61M -43.9%-57.1%4.4%
DRIODarioHealth Corp.LTM Mar 2026$5.51M -51.1%-18.0%26.0%
INNVInnovAge Holding Corp.LTM Mar 2026$3.36M -56.6%+26.8%0.4%
CYHCommunity Health Systems, Inc.LTM Mar 2026$3M ——0.0%
Peer median (excluding AIRS) $11.07M-2.4%+3.4%5.6%

Competitors are the stored peer set for AIRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income10.55M(14.68M)(4.48M)(8.25M)(11.67M)
Depreciation & Amortization6.6M8.06M10.25M11.89M12.78M
Deferred Income Tax208K1.13M1.34M(252K)(5.91M)
Stock-Based Compensation7.19M29.46M18.22M3.76M2.33M
Change in Working Capital771K(1.53M)(1.38M)3.85M(1.69M)
Accounts Receivables0(2.83M)890K(1.12M)1.56M
Inventory00000
Accounts Payables1.58M865K(206K)739K579K
Other Working Capital(805K)440K(2.06M)4.22M(3.82M)
Other Non-Cash Items1.32M2M(5K)355K7.25M
Operating Cash Flow26.63M24.45M23.96M11.35M3.1M
Capital Expenditures(7.12M)(12.92M)(9.92M)(14.01M)(2.4M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow(7.12M)(12.92M)(9.92M)(14.01M)(2.4M)
Debt Repayment48.77M(760K)(12.13M)2.88M(19.19M)
Common Stock Issued13.54M00018.76M
Common Stock Repurchased00(233K)(903K)0
Dividends Paid(66.86M)(24.32M)(464K)(252K)0
Other Financing Activities0(2.18M)(569K)(1.09M)(56K)
Financing Cash Flow(4.55M)(27.26M)(13.39M)630K(478K)
Effect of Forex Changes00000
Net Change in Cash14.97M(15.73M)646K(2.03M)214K
Free Cash Flow19.52M11.53M14.04M(2.66M)692K

AirSculpt Technologies, Inc.

NASDAQ:AIRS

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.